Hello, this is Dave Lynn, and I’m a partner in Goodwin’s Capital Markets practice and chair of the firm’s Public Company Advisory practice. This is New Directions, a series of discussions about the impact and trajectory of...more
4/23/2025
/ Broker-Dealer ,
Capital Formation ,
Capital Markets ,
Corporate Governance ,
Deregulation ,
Enforcement Priorities ,
Financial Regulatory Reform ,
Investment Management ,
Publicly-Traded Companies ,
Regulatory Reform ,
Regulatory Requirements ,
Rulemaking Process ,
Securities and Exchange Commission (SEC) ,
Trump Administration
The Staff of the Division of Corporation Finance at the Securities and Exchange Commission (SEC) has recently begun issuing comment letters in the life sciences reverse merger (RM) context that involve a broadened...more
1/22/2024
/ Capital Formation ,
Compliance ,
Form 8-K ,
Form S-1 ,
Life Sciences ,
Mergers ,
Publicly-Traded Companies ,
Recapitalization ,
Resales Agreements ,
Reverse Mergers ,
Rule 144 ,
SEC Comment Letter Process ,
Securities and Exchange Commission (SEC) ,
Shell Corporations